G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 1, 1996, Pages 63-71

  Harada, Mine ^a   Nagafuji, Koji ^b   Fujisaki, Tomoaki ^b   Kubota, Akira ^b   Mizuno, Shin Ichi ^b   Takenaka, Katsuto ^b   Miyamoto, Toshihiro ^b   Ohno, Yuju ^b   Gondo, Hisashi ^b   Kuroiwa, Mika ^b   Okamura, Takashi ^b   Inaba, Shoichi ^b   Niho, Yoshiyuki ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BLOOD TOXICITY; BONE PAIN; CANCER; CANCER CHEMOTHERAPY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MEGADOSE; FATIGUE; FEVER; HEADACHE; HUMAN; HUMAN CELL; LIVER TOXICITY; MALE; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANTIGENS, CD34; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PLATELET AGGREGATION; REFERENCE VALUES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029738286     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.63     Document Type: Article

References (30)

1. Lowry, P.A. & Tabbara, I.A. Peripheral hematopoietic stem cell transplantation: Current concepts. Exp. Hematol. 20:937, 1992.
2. Gale, R.P., Juttner, C.A. & Henon, P. Blood Stem Cell Transplants. Cambridge University Press, Cambridge, UK, 1994.
3. Sheridan, W.P., Begley, C.G., Juttner, C.A., et al. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992.
4. To, L.B., Roberts, M.M., Haylock, D.N., et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant. 9:277, 1992.
5. Elias, A.D., Ayash, L., Anderson, K.C., et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036, 1992.
6. Teshima, T., Harada, M., Takamatsu, Y., et al. Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Bone Marrow Transplant. 10:215, 1992.
7. Bensinger, W., Singer, J., Appelbaum, F., et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993.
8. Chao, N.J., Schriber, J.R., Grimes, K., et al. Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031, 1993.
9. Russell, N.H., Hunter, A., Rogers, S., et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 341:1482, 1993.
10. Weaver, C.H., Bensinger, W., Longin, K., et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 82:1981, 1993.
11. Matsunaga, T., Sakamaki, S., Kongo, Y., et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant. 11:103, 1993.
12. Dreger, P., Suttorp, M., Haferlach, T., et al. Allogenic G-CSF-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 81:1404, 1993.
13. Teshima, T., Harada, M., Takamatsu, Y., et al. Granulocyte colony-stimulating factor (G-CSF)-induced mobilization of circulating haemopoietic stem cells. Br. J. Haematol. 84:570, 1993.
14. Shimoda, K., Okamura, S., Harada, N., et al. Granulocyte colony-stimulating factor receptors on human acute leukemia: Biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors. Cancer Res. 52:3052, 1992.
15. Fukuda, T., Okamura, S., Shimoda, K., et al. Predominance of myeloid antigens in CD34-positive peripheral blood stem cells over those in bone marrow, after the administration of granulocyte colony-stimulating factor. Eur. J. Haematol. 52:201, 1994.
16. Cashman, J., Eaves, A.C. & Eaves, C.J. Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood 66:1002, 1985.
17. Eaves, C.J., Cashman, J.D. & Eaves, A.C. Methodology of long-term culture of human hematopoietic cells. J. Tissue Culture Methods 13:55, 1991.
18. Sutherland, H.J., Lansdorp, P.M., Henkelman, D.H., et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc. Natl. Acad. Sci. USA 87:3584, 1990.
19. Udomsakdi, C., Lansdorp, P.M., Hogge, D.E., et al. Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood 80:2513, 1992.
20. Shimoda, K., Okamura, S., Harada, N., et al. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J. Clin. Invest. 91:1310, 1993.
21. Dreger, P., Haferlack, T., Eckstein, V., et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br. J. Haematol. 87:609, 1994.
22. Lindemann, A., Herrmann, F., Oster, W., et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 74:2644, 1989.
23. Kessinger, A., Smith, D.M., Strandjord, S.E., et al. Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant. 4:643, 1989.
24. Goldon, M.Y. & Blackett, N.M. Some factors determing the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplant. 15:659, 1995.
25. Bender, J.G., To, L.B., William, S., et al. Defining a therapeutic dose of peripheral blood stem cells. J. Hematother. 1:329, 1992.
26. Bensinger, W.I., Weaver, C.H., Appelbaum, F.R., et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995.
27. Körbling, M., Przepioka, D., Huh, Y.O., et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995.
28. Schmitz, N., Dreger, P., Suttorp, M., et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (granulocyte colony-stimulating factor). Blood 85:16 66, 1995.
29. Shimoda, K., Okamura, S., Inaba, S., et al. Granulocyte colony-stimulating factor and platelet aggregation. Lancet 341:633, 1993.
30. Conti, J.A. & Sher, H.L. Acute arterial thrombosis after escalated-dose methotrexate, vincristine, doxorubicin, cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. Cancer 70:2699, 1992.